Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets, Volume 6 - Number 4








Regulation of the Neuronal Fate by ΔFosB and its Downstream Target, Galectin-1

, 6(4): 437 - 444

Tomofumi Miura, Yoshinori Ohnishi, Hideaki Kurushima, Hidenori Horie, Toshihiko Kadoya and Yusaku Nakabeppu


DOI: 10.2174/1389450054021963



Blockade of Diabetic Vascular Injury by Controlling of AGE-RAGE System

, 6(4): 447 - 452

Khin Mar Myint, Yasuhiko Yamamoto, Shigeru Sakurai, Ai Harashima, Takuo Watanabe, Hui Li, Akihiko Takeuchi, Kazunobu Yoshimura, Hideto Yonekura and Hiroshi Yamamoto


DOI: 10.2174/1389450054021882







Vascular Endothelial Growth Factor and Diabetic Retinopathy: Role of Oxidative Stress

, 6(4): 511 - 524

Ruth B. Caldwell, Manuela Bartoli, M. Ali Behzadian, Azza E.B. El-Remessy, Mohamed Al-Shabrawey, Daniel H. Platt, Gregory I. Liou and R. William Caldwell


DOI: 10.2174/1389450054021981




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Advertisement

webinar-July-21

Related Journals

Related eBooks

eBooks Catalog